810223 | C12-NBD Glucosyl Ceramide
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1'-sphingosine

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
C12-NBD Glucosyl Ceramide
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1'-sphingosine
CAS Registry Number is a Registered Trademark of the American Chemical Society
Gong LL, Yang S, Zhang W, Han FF, Lv YL, Xuan LL, Liu H, Liu LH. Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC-MS based lipidomics approach. J Pharm Biomed Anal. 2020 Jan 5;177:112848. doi: 10.1016/j.jpba.2019.112848. Epub 2019 Aug 29.
PubMed ID: 31479998- Certificate of Analysis (Lot No. 810223C-250UG-A-012 and 5394CEA012)
- Certificate of Analysis (Lot No. 810223P-250UG-A-012 and 5394PEA012)
- Certificate of Analysis (Lot No. 810223P-250UG-B-012 and 5394PEB012)
- Certificate of Analysis (Lot No. 810223P-250UG-A-013 and 5394PEA013)